Why is Auro Labs. falling/rising?

As of 24-Sep, Auro Laboratories Ltd is currently priced at 240.95, with no change in price (0.00%). The stock has shown a performance today that outperformed its sector by 0.45%. It is trading higher than its 5-day and 20-day moving averages, although it remains below its 50-day, 100-day, and 200-day moving averages. The stock has experienced a 2.97% increase over the past week, contrasting with a decline of 3.50% over the past month. Despite generating a 21.60% return over the last year, the company has faced significant challenges, including a -17.34% annual growth rate in net sales and negative results for the last four consecutive quarters, which have likely contributed to investor caution.
In the broader market context, Auro Laboratories Ltd has outperformed the Sensex by 4.15% over the past week, as the benchmark index has declined by 1.18%. However, the stock's year-to-date performance is concerning, with a decline of 9.79% compared to the Sensex's gain of 4.58%. The company's high management efficiency, indicated by a ROCE of 19.26%, contrasts sharply with its poor long-term growth metrics, which may create a mixed sentiment among investors. While the stock has shown strong historical returns over the last three years, the recent negative trends in sales and profits suggest that the market may be reacting to underlying weaknesses, leading to a cautious outlook despite some positive short-term movements.